B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gsk 180736a

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gsk 180736a, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

gsk
2 shared targets
balanol
2 shared targets
uprosertib
3 shared targets
upadacitinib
2 shared targets
bisindolylmaleimide
2 shared targets
capivasertib
2 shared targets
hydroxyfasudil
3 shared targets · score 27.5
tofacitinib
2 shared targets
pf
3 shared targets
enzastaurin
2 shared targets
Loading evidence profile...

This evidence profile for Gsk 180736a is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.